Mast cells in central nervous system neoplasms: an immunohistochemical study

IF 0.5 Q4 CLINICAL NEUROLOGY
Aldair Ochoa-Rojas, A. Calderón-Garcidueñas, César I. PenÓa-Ruelas, R. Ruiz-Ramos, Noé López-Amador, E. Villarreal-Ríos, E. Castelán-Maldonado
{"title":"Mast cells in central nervous system neoplasms: an immunohistochemical study","authors":"Aldair Ochoa-Rojas, A. Calderón-Garcidueñas, César I. PenÓa-Ruelas, R. Ruiz-Ramos, Noé López-Amador, E. Villarreal-Ríos, E. Castelán-Maldonado","doi":"10.24875/rmn.22000085","DOIUrl":null,"url":null,"abstract":"Objective: To investigate the relationship between mast cells (MCs) and different central nervous system (CNS) tumors. Methods : It was a comparative immunohistochemical study to investigate the presence, number, and location of MCs in pilocytic astrocytomas, glioblastoma, medulloblastoma, ependymoma, meningioma, and immature and mature terato-mas. Means, medians, and standard deviation were obtained. Comparation in the number of MCs in the different tumors was carried out using the Mann–Whitney test (p < 0.05). Results: There was a significant difference in the number of MCs between pilocytic astrocytoma ( X ̅ = 0), and mature teratoma ( X ̅ = 65), in relation to the other neoplasms ( X ̅ = 3-11.4). MCs were identified in meningeal lining in meningiomas, in the perivascular space in ependymomas and in the tumor stroma and perivascular space in the rest of the tumors analyzed. Conclusions: MCs appear to play different roles in CNS tumors. Its absence in pilocytic astrocytomas and its presence in glioblastomas suggests a role in the latter, probably related to angiogenesis. The maximum number of MCs was observed in mature teratomas, specifically in relation to stratified squamous epithelium, possibly in relation to trophic factors that contribute to epithelial renewal and maintenance. These findings call for future research to determine if MCs can be a therapeutic target or are important as a prognostic factor.","PeriodicalId":53921,"journal":{"name":"Revista Mexicana de Neurociencia","volume":" ","pages":""},"PeriodicalIF":0.5000,"publicationDate":"2023-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Mexicana de Neurociencia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24875/rmn.22000085","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To investigate the relationship between mast cells (MCs) and different central nervous system (CNS) tumors. Methods : It was a comparative immunohistochemical study to investigate the presence, number, and location of MCs in pilocytic astrocytomas, glioblastoma, medulloblastoma, ependymoma, meningioma, and immature and mature terato-mas. Means, medians, and standard deviation were obtained. Comparation in the number of MCs in the different tumors was carried out using the Mann–Whitney test (p < 0.05). Results: There was a significant difference in the number of MCs between pilocytic astrocytoma ( X ̅ = 0), and mature teratoma ( X ̅ = 65), in relation to the other neoplasms ( X ̅ = 3-11.4). MCs were identified in meningeal lining in meningiomas, in the perivascular space in ependymomas and in the tumor stroma and perivascular space in the rest of the tumors analyzed. Conclusions: MCs appear to play different roles in CNS tumors. Its absence in pilocytic astrocytomas and its presence in glioblastomas suggests a role in the latter, probably related to angiogenesis. The maximum number of MCs was observed in mature teratomas, specifically in relation to stratified squamous epithelium, possibly in relation to trophic factors that contribute to epithelial renewal and maintenance. These findings call for future research to determine if MCs can be a therapeutic target or are important as a prognostic factor.
中枢神经系统肿瘤中肥大细胞的免疫组化研究
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Revista Mexicana de Neurociencia
Revista Mexicana de Neurociencia CLINICAL NEUROLOGY-
自引率
0.00%
发文量
28
审稿时长
28 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信